Current status and perspectives of tyrosine kinase inhibitor treatment in the posttransplant period in patients with chronic myelogenous leukemia (CML). (Q37594993)
Jump to navigation
Jump to search
scientific article published on 08 September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Current status and perspectives of tyrosine kinase inhibitor treatment in the posttransplant period in patients with chronic myelogenous leukemia (CML). |
scientific article published on 08 September 2009 |
Statements
1 reference
Current status and perspectives of tyrosine kinase inhibitor treatment in the posttransplant period in patients with chronic myelogenous leukemia (CML). (English)
1 reference
Ulrike Bacher
1 reference
Evgeny Klyuchnikov
1 reference
Nicolaus Kröger
1 reference
Tim H Brummendorf
1 reference
Bettina Wiedemann
1 reference
Axel Rolf Zander
1 reference
8 September 2009
1 reference
1 reference
Identifiers
1 reference